ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SMD Spectral Md Holdings Ltd

58.00
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Spectral Md Holdings Ltd SMD London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 58.00 01:00:00
Open Price Low Price High Price Close Price Previous Close
58.00 58.00
more quote information »
Industry Sector
HEALTH CARE EQUIPMENT & SERVICES

Spectral Md SMD Dividends History

No dividends issued between 25 Apr 2014 and 25 Apr 2024

Top Dividend Posts

Top Posts
Posted at 07/9/2023 15:34 by rimau1
SMD delists tonight and heads across the pond. Whether it closes at 60p, £1 or 20p couldn’t be less relevant. Be a nice chap and just give £20 to charity anyway, call it a fine for having no idea what is happening here.
Posted at 06/9/2023 15:57 by rimau1
That is a complicated question that would require a very long response and i suppose means you don’t understand the structure of the transaction. SMD have a good presentation on their website. Highly unlikely to double but could get a decent kicker if rosecliff (who are being paid a few million quid) manage to raise new funds at the top of the $10m-$30m range.
Posted at 06/9/2023 15:37 by rimau1
I suppose RCLF with announce it today and SMD via an rns either at 5pm or tomorrow? I listened in to the meeting, vote was passed. No idea when if gets physically announced! Trading starts Friday.
Posted at 22/8/2023 08:48 by idomeneo
WH Island note: "The proposed merger EV also stands at a discount to our sum-of-the-parts fair valuation of SMD of 157p per share"
Posted at 10/8/2023 10:47 by rimau1
8th september for the delisting on AIM and listing on Nasdaq. SMD shareholders will own £17m ordinary shares in the new company at $10.17 a share. Obviously the stock could tank on relisting and it might be a few days before broking accounts are updated to trade the new shares but there is a theoretical paper profit of 100% at todays prices.
Posted at 01/8/2023 08:35 by rimau1
New presentation released which provides a good investment case, clear why Rosecliff are willing to pay a premium to snare SMD.
Posted at 23/6/2021 05:13 by rambutan2
Conclusiona from the Experts Report pgs70-91, which is very well worth a read:

7. Conclusions
Development and commercialisation of new medical devices in healthcare is a high-risk activity but when executed successfully can deliver significant rewards. For SMD to achieve its potential as a provider of medical devices in the wound healing sector, assuming that the DFU and burns clinical trials are successful, its commercial success will rely to a greater degree on adoption and penetration into US and EU markets. This will require significant sales and marketing efforts in penetrating clinical networks in both territories as well as successfully navigating the various regulatory and payer communities. The Company is cognisant of these requirements and appears to have appropriate plans to address these, some of which have already been or are being implemented.

Many of the technical and development risks appear to have been addressed through the evolution of the system through 1st and 2nd generation systems. Final proving of the 3rd generation system’s capabilities has yet to be completed which is the purpose of the ongoing and planned clinical trials. If the system performs as expected in those trials, there appear to be few if any competing systems in the market or late-stage development that can provide the same analytical and predictive capabilities of the DeepviewĀ® device. Whilst this does not guarantee commercial success, it would mean that the device would likely be regarded best in class in a clinical setting with limited diagnostic capability.

The future development plans and commercialisation of its technology in different markets will likely mean that SMD will require further funding beyond that provided under the BARDA agreement and any funds from a successful new issue on AIM. Whilst there is no guarantee that such future funding will materialise, good clinical data from the ongoing and planned clinical trials will position it well for regulatory and commercial success.
Posted at 22/6/2021 15:19 by rambutan2
Admission to trading on AIM

& First Day of Dealings

LONDON, U.K. AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd., a predictive analytics group that develops proprietary AI algorithms and optical technology for faster treatment decisions in wound care, is pleased to announce the admission of its entire issued share capital, being 136,077,064 shares of common stock, to trading on AIM ("Admission") will take place and dealings will commence at 8.00 a.m. today under the ticker 'SMD' and ISIN 'USU8457V1099'.

The Company's Admission Document was published on 16 June 2021 and is available here:

Summary and Highlights:

-- Oversubscribed Placing for gross proceeds of GBP11.3 million (c.US$16 million)
-- The Placing was conducted at a pre-IPO fully diluted valuation of GBP95m
-- Placing price per share of common stock of 59 pence
-- Market capitalisation (at the Placing Price) of approximately GBP80 million on Admission
-- The 19,067,797 shares of New Common Stock being placed represent c. 14 per cent. of the Enlarged Share Capital
Posted at 03/12/2020 02:01 by stu31
Strategic Metals Ltd. Announces New Normal Course Issuer Bid to Succeed the Normal Course Issuer Bid Which Will Expire on December 2, 2020

Vancouver, BC - November 30, 2020 – Strategic Metals Ltd. (TSX-V: SMD) (“Strategic221;) announces that it is making a new Normal Course Issuer Bid (the “New Bid”) pursuant to the provisions of TSX Venture Exchange Policy 5.6, to succeed its existing Normal Course Issuer Bid (the “Old Bid”), as accepted by the TSX Venture Exchange on November 28, 2019.

Strategic has purchased no shares under the Old Bid, which will expire on December 2, 2020. The New Bid will consist of the acquisition by Strategic of up to 8,700,000 common shares of its capital stock, representing approximately 10% of the “public float” of 87,599,346 common shares upon the date of commencement of the New Bid. (There are currently 106,705,767 common shares of Strategic issued and outstanding.) The New Bid will commence on December 3, 2020, and will expire on December 2, 2021.

Strategic is making the New Bid, to succeed the Old Bid (which was limited to an aggregate of 6,600,000 common shares), because it is of the opinion that fluctuating global market conditions periodically (and currently) may result in unwarranted reductions in Strategic’s share price that do not reflect the underlying value of its assets. Strategic will utilize unallocated cash resources to effect purchases under the New Bid with a view to capitalizing on these potential price weaknesses. Shares purchased under the New Bid will be made at Management’s discretion based on market conditions, and will be returned to Strategic’s treasury for cancellation.
Posted at 15/8/2020 01:12 by stu31
Strategic Metals: Latest on Mt. Hinton & high-grade opportunities
by @JamesKwantes on 4 Aug 2020, 11:29

I caught up with Strategic Metals $SMD CEO Doug Eaton recently to talk about Mt. Hinton and other irons in the fire. Two diamond drills are turning at Mt. Hinton, an area of high-grade gold and silver mineralization in Yukon's Keno Hill district adjacent to Alexco's property. Strategic plans a 7,000-metre drill program and Eaton expects that drilling could continue into early October this season.

The recently closed $4-million financing gives Strategic the capacity to expand - even double - the program, results and weather permitting. With gold near US$2,000 an ounce, the timing couldn't be better.

Strategic is a pretty compelling sum-of-the parts story beyond its wholly owned Mt. Hinton project. The company, one of three Resource Opportunities sponsors, has about $12 million in cash and roughly $27 million in shareholdings (current SMD market cap $77 million). Strategic also has about 80 wholly owned precious metals projects available for option, several of which Eaton says are high-quality enough standalone projects for a company to go public on.



00:00 Introduction

00:16 Mt. Hinton plans and drill progress

06:00 Under the hood, Part 1: Major SMD shareholdings and upcoming catalysts

06:30 Rockhaven Resources: New PEA, large drilling program possible

08:11 Precipitate Gold: Barrick JV and drilling on wholly owned project in DR

08:35 Trifecta Gold: Drill permitting underway for Yuge project in Nevada

08:50 GGL Resources: B.C. project w/ porphyry/epithermal targets, new Nevada acquisition

10:55 Under the hood, Part 2: Precious metals properties available for option

12:09 Plata: High-grade silver plus gold; past producer

15:06: Alotta: Porphyry/vein targets; 40 km from Western's Casino deposit

16:24 Hopper: Porphyry target with similarities to Casino

18:02 Groundhog: High-grade silver prospect w/ gold

19:37 Gold price and market sentiment

Your Recent History

Delayed Upgrade Clock